EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Genes & cancer

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1947601913489569PMID 24069508PMCID PMC3782006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions

  2012cited by this paper
• Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels.

  2012cited by this paper
• Dysregulated expression of secretogranin III is involved in neurotoxin‐induced dopaminergic neuron apoptosis

  2012cited by this paper
• PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.

  2012cited by this paper
• Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription.

  2012cited by this paper
• Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

  2012cited by this paper
• MotifMap: integrative genome-wide maps of regulatory motif sites for model species

  2011cited by this paper
• The Ewing sarcoma protein regulates DNA damage-induced alternative splicing.

  2011cited by this paper
• Chromogranin A--serum marker for prostate cancer.

  2011cited by this paper
• Supplementary Figure S7

  2011cited by this paper
• The Master Negative Regulator REST/NRSF Controls Adult Neurogenesis by Restraining the Neurogenic Program in Quiescent Stem Cells

  2011cited by this paper
• ZINBA integrates local covariates with DNA-seq data to identify broad and narrow regions of enrichment, even within amplified genomic regions

  2011cited by this paper
• Cotranscriptional exon skipping in the genotoxic stress response

  2010cited by this paper
• The Transcription Factor REST Is Lost in Aggressive Breast Cancer

  2010cited by this paper
• CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

  2010cited by this paper
• Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes

  2010cited by this paper
• REST selectively represses a subset of RE1-containing neuronal genes in mouse embryonic stem cells

  2009cited by this paper
• Gene set enrichment analysis made simple

  2009cited by this paper
• Regulation of non-coding RNA networks in the nervous system--what's the REST of the story?

  2009cited by this paper
• SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer

  2009cited by this paper
• GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance

  2009cited by this paper
• A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis.

  2009cited by this paper
• Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines.

  2009cited by this paper
• Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer

  2008cited by this paper
• Induced ncRNAs Allosterically Modify RNA Binding Proteins in cis to Inhibit Transcription

  2008influential reference
• A New Binding Motif for the Transcriptional Repressor REST Uncovers Large Gene Networks Devoted to Neuronal Functions

  2007cited by this paper
• REST in good times and bad: roles in tumor suppressor and oncogenic activities.

  2006cited by this paper
• Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.

  2006cited by this paper
• NR0B1 Is Required for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma

  2006cited by this paper
• TLS, EWS and TAF15: a model for transcriptional integration of gene expression.

  2006cited by this paper
• IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation.

  2005cited by this paper
• Small CTD Phosphatases Function in Silencing Neuronal Gene Expression

  2005cited by this paper
• Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16

  2005cited by this paper
• A genetic screen for candidate tumor suppressors identifies REST.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.

  2005cited by this paper
• Brain-Derived Neurotrophic Factor-Induced Gene Expression Reveals Novel Actions of VGF in Hippocampal Synaptic Plasticity

  2003cited by this paper
• Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein

  2003cited by this paper
• Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor α1 subunit in small-cell lung cancer cells

  2003cited by this paper
• The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts.

  2002cited by this paper
• The Pro-Oncoprotein EWS (Ewing’s Sarcoma Protein) Interacts with the Brn-3a POU Transcription Factor and Inhibits its Ability Activate Transcription

  2002cited by this paper
• Supplemental Information for

  2002cited by this paper
• The EWS protein is dispensable for Ewing tumor growth.

  2001cited by this paper
• Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno‐ultrastructural study indicating neuroendocrine differentiation

  2001cited by this paper
• A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker.

  2000cited by this paper
• Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.

  2000cited by this paper
• EWS·Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA Splicing*

  2000cited by this paper
• Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance.

  1999cited by this paper
• EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.

  1999cited by this paper
• Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues.

  1999cited by this paper
• Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns.

  1998cited by this paper
• EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes

  1998cited by this paper
• Identification of a novel gene, PSD, adjacent to NFKB2/lyt-10, which contains Sec7 and pleckstrin-homology domains.

  1997cited by this paper
• Developmental Regulation of Synaptotagmin I, II, III, and IV mRNAs in the Rat CNS

  1997cited by this paper
• Identification of potential target genes for the neuron-restrictive silencer factor.

  1996cited by this paper
• Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

  1995cited by this paper
• Experimental evidence for a neural origin of Ewing's sarcoma of bone.

  1987cited by this paper
• Characterization of neural cell adhesion molecules (NCAM) expressed by ewing and neuroblastoma cell lines

  1987cited by this paper
• Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumors.

  1984cited by this paper
• Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12).

  1984cited by this paper
• Chromosome translocation in peripheral neuroepithelioma.

  1984cited by this paper

• REST Is Not Resting: REST/NRSF in Health and Disease

  2023cites this paper
• The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance.

  2022cites this paper
• Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas.

  2022cites this paper
• Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription

  2021cites this paper
• Chromatin profiling reveals reorganization of lysine specific demethylase 1 by an oncogenic fusion protein

  2020cites this paper
• Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein

  2020cites this paper
• Fusion protein EWS-FLI1 is incorporated into a protein granule in cells

  2020influential citation
• Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis

  2019influential citation
• Imaging dynamic and selective low-complexity domain interactions that control gene transcription

  2018cites this paper
• Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis

  2018cites this paper
• EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma

  2017cites this paper
• REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature

  2017cites this paper
• Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma

  2017cites this paper
• Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting

  2016influential citation
• EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma

  2015cites this paper
• Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth

  2014cites this paper
• EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing’s Sarcoma

  2014cites this paper
• Targeting Glutathione S-transferase M4 in Ewing sarcoma

  2014cites this paper
• Differential co-expression analysis of a microarray gene expression profiles of pulmonary adenocarcinoma.

  2014cites this paper
• Cancer Therapy : Preclinical Reversible LSD 1 Inhibition Interferes with Global EWS / ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth

  2014cites this paper
• Adhesion in Ewing Sarcoma Oncogenic Transformation and Cellular A Novel Role for Keratin 17 in Coordinating

  2014cites this paper
• A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma

  2013cites this paper